This BNMS new award for 2019 is to celebrate teams that are developing innovative and creative ways of improving the services they deliver.
The aim of this award is to encourage innovation leading to improvement in procedures, practices and service levels.
It is hoped that ideas put forward by the competing teams can be adopted by other departments for improving service. Select the image to view the flyer
Entries are welcomed from teams/departments across the UK of two or more people from any craft group who have applied an innovative project or processes in their department.
Entries should be made online via the form on the BNMS website www.bnms.org.uk
The top 3 scoring entries will be invited to create a short video featuring their team and their innovative project.
The finalists’ videos will be published on the BNMS website and will be shown at the Spring meeting where both members and delegates will be invited to vote for their favourite team/entry.
At the Spring meeting delegates will be invited to view the videos and vote for their favourite team.
The winners will be announced at the Presidents reception and will be awarded a plaque.
Submissions are now open. Apply here
Find the rules and instructions here
The deadline for submissions is 3rd January 2019 at 5pm
The President’s Reception will be held on Monday 1st April 2019 in Oxford at 6pm at the King’s Centre Oxford.
The purpose of BNMS social media accounts is to increase awareness of the BNMS and the specialty of nuclear medicine, enhancing the Society’s image and advancing its objectives through communications. Primarily communications for initiatives and developments or news in nuclear medicine practice, marketing educational meetings, encouraging BNMS membership applications and traffic to the BNMS website.
The following representatives contribute to social media channels on behalf of BNMS:
David Little, Royal United Hospital Bath,
Luisa Roldao Pereira, Maidstone and Tunbridge Wells NHS Trust
Charlotte Weston, BNMS Staff
Le Thoai, BNMS Staff
Caroline Oxley, BNMS Staff
BNMS social media principles apply to professional use of social media on behalf of BNMS as well as personal use of social media when referencing BNMS.
P17: Myocardial suppression in FDG PET/CT in infective endocarditis: A single site experience in patient preparation
Sara Soares, Nick Gulliver, Andrew Cheetham, Manuela Vadrucci, Nicola Mulholland and Gill Vivian
King's College Hospital NHS Foundation Trust, London
BNMS President, Dr John Buscombe visited Sara Soares to present the certificate
The magazine is fully dedicated to educate non-nuclear medicine professionals about diagnostic and therapeutic nuclear medicine procedures and to promote the safe use of nuclear medicine for the betterment of the populations' health across the globe.
Dr John Buscombe from Addenbrooke's Hospital Cambridge takes over as President from Prof Sobhan Vinjamuri (President from 2016 to 2018) at the closing ceremony of the BNMS Annual Spring Meeting in Birmingham on Monday 16th April 2018.
Following a period of process development and successful reviewer recruitment, the HRA have opened Phase 1 of Radiation Assurance to all oncology studies taking place in the NHS.
Information and guidance on Radiation Assurance can be found on their website.
The BNMS is seeking members to form a working party in molecular radiotherapy (MRT). The field is expanding rapidly with the introduction of new radiotherapeutics and legislation.
The group will be expected to address a number of issues including, but not limited to:
Drafting of a position statement in response to the new Basic Safety Standards (Euratom 2013/59)
Investigation of models of service delivery to ensure equality of access to innovative treatments
Promotion of research and development, including support for clinical trials
Engagement with similar bodies, including CTRad, iDUG, IPEM, UKRG.
If you would like to express an interest in this working group, or have any questions, please contact the BNMS at:firstname.lastname@example.org
The Clinical and Translational Radiotherapy Research Working Group (CTRad) encourages submissions of proposals of clinical trials. Proposals are discussed at regular meetings and reviewed openly. The support of CTRad is extremely beneficial to obtain support funding from the CRUK. The BNMS would be pleased to discuss and support any proposals for clinical trials involving radiotherapeutics or radiodiagnostics.
Please contact the BNMS in the first instance if any advice is required at email@example.com